FDA NDC Directory · JSON-LD · Markdown

TECENTRIQ

NDC 50242-918 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameatezolizumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761034
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsATEZOLIZUMAB (840 mg/14mL)
Marketing started20190308
Package count1

External sources

Source: openFDA. Public-domain (CC0).